Shehnaaz Suliman

Shehnaaz Suliman is a Director at 10X Genomics. Shehnaaz has also served as the President and Chief Operating Officer at Alector from December 2019 to January 2022. Prior to that, they were a part of the team at 10x Genomics. Shehnaaz has also served as the Senior Vice President Corporate Development and Strategy at Theravance Biopharma US, Inc. from July 2017 to March 2019. Shehnaaz was also the Vice President and Global Head of Immunology, Infectious Diseases and Specialty Care at Roche Partnering from May 2015 to July 2017.

Shehnaaz Suliman has an MBA with Distinction from Saïd Business School, University of Oxford. Shehnaaz also has an MPhil in Development Studies from the University of Oxford, and an MBChB (M.D.) with Class Medal from the University of Cape Town.